ducovest

IXG:NYE-iShares Global Financials ETF (USD)

ETF | Financial |

Last Closing

USD 102.19

Change

0.00 (0.00)%

Market Cap

N/A

Volume

4.84K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-27 )

Largest Industry Peers for Financial

Symbol Name Price(Change) Market Cap
XLF Financial Select Sector SPDR®..

N/A

 USD 46.97B
VFH Vanguard Financials Index Fund..

N/A

 USD 10.92B
FNCL Fidelity® MSCI Financials Ind..

N/A

 USD 2.02B
FXO First Trust Financials AlphaDE..

N/A

 USD 1.87B
BIZD VanEck BDC Income ETF

N/A

 USD 1.39B
VPC Virtus Private Credit ETF

N/A

 USD 0.07B
BDCZ UBS AG London Branch ELKS 4

N/A

 USD 0.02B
IYF iShares U.S. Financials ETF

N/A

 N/A
IYG iShares U.S. Financial Service..

N/A

 N/A
IAI iShares U.S. Broker-Dealers & ..

N/A

 N/A

ETFs Containing IXG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Financial) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.38% 100% F 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.38% 100% F 85% B
Trailing 12 Months  
Capital Gain 21.38% 94% A 88% B+
Dividend Return 3.01% 82% B 53% F
Total Return 24.39% 100% F 89% A-
Trailing 5 Years  
Capital Gain 105.04% 47% F 79% B-
Dividend Return 19.94% 82% B 53% F
Total Return 124.97% 65% D 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 13.78% 59% D- 77% C+
Dividend Return 16.02% 53% F 77% C+
Total Return 2.24% 71% C- 51% F
Risk Return Profile  
Volatility (Standard Deviation) 20.69% 71% C- 49% F
Risk Adjusted Return 77.43% 88% B+ 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike